Professor A. M. El-Mowafy of Mansoura University’s Department of Biochemistry and associates administered 125 milligrams per kilogram (mg/kg) DHA, 250 mg/kg of DHA, cisplatin alone, cisplatin combined with 125 mg/kg DHA, or a control substance to groups of 8 to 10 mice implanted with mammary carcinoma cells. A group of mice not implanted with tumor cells served as controls. Serum C-reactive protein (CRP, a marker of inflammation), white blood cells, and MDA (a marker of lipid peroxidation) were measured, and tumor development was assessed after 20 days. Continue Reading
No comments:
Post a Comment